You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-525

Showing 51 - 75 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Worldwide (PP6M, PP3M 350 mg eq., PP3M 525 mg eq.)

Completed
Has Results
  • Schizophrenia
  • Rogers, Arkansas
  • +137 more
Nov 11, 2021

Parkinson's Disease Trial in United States (ABBV-951)

Recruiting
  • Parkinson's Disease
  • Aurora, Colorado
  • +9 more
Jun 7, 2022

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)

Completed
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +159 more
Dec 19, 2022

NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Santa Monica, California
  • +25 more
Jun 27, 2022

Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)

Recruiting
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +35 more
Jan 12, 2023

Parkinson's Disease (PD) Trial in Australia, United States (ABBV-951)

Enrolling by invitation
  • Parkinson's Disease (PD)
  • Birmingham, Alabama
  • +52 more
Oct 17, 2022

Parkinson's Disease Trial in Puerto Rico, United States (ABBV-0805, Placebo ABBV-0805)

Withdrawn
  • Parkinson's Disease
  • Gainesville, Florida
  • +5 more
Dec 13, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-154, Placebo)

Active, not recruiting
  • Rheumatoid Arthritis (RA)
  • Phoenix, Arizona
  • +222 more
Jun 7, 2022

Polymyalgia Rheumatica Trial in Worldwide (ABBV-154, Placebo, Glucocorticoid)

Recruiting
  • Polymyalgia Rheumatica
  • Jonesboro, Arkansas
  • +118 more
Aug 11, 2022

Ulcerative Colitis (UC) Trial in Worldwide (ABBV-323 Dose A, ABBV-323 Dose B)

Completed
  • Ulcerative Colitis (UC)
  • ABBV-323 Dose A
  • ABBV-323 Dose B
  • Tucson, Arizona
  • +33 more
Mar 10, 2022

CoronaVirus Disease-2019 (COVID-19) Trial in Worldwide (ABBV-47D11, Placebo for ABBV-47D11, ABBV-2B04)

Completed
  • CoronaVirus Disease-2019 (COVID-19)
  • Glendale, California
  • +17 more
Aug 30, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Parkinson's Disease (PD) Trial in Worldwide (ABBV-951)

Enrolling by invitation
  • Parkinson's Disease (PD)
  • Birmingham, Alabama
  • +49 more
Jan 18, 2022

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +56 more
Nov 15, 2021

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Pancreatic Cancer Trial in Worldwide (ABBV-927, Budiglimab, modified FOLFIRINOX)

Recruiting
  • Pancreatic Cancer
  • Springdale, Arkansas
  • +23 more
May 23, 2022

Posttraumatic Headache Trial (Cognitive Behavioral Therapy for Posttraumatic Headache, Treatment as Usual, Telemedicine-based

Not yet recruiting
  • Posttraumatic Headache
  • Cognitive Behavioral Therapy for Posttraumatic Headache
  • +2 more
  • (no location specified)
Jan 12, 2023

Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)

Active, not recruiting
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +9 more
Mar 23, 2022

Psoriasis Trial in United States (ABBV-157, Placebo for ABBV-157)

Completed
  • Psoriasis
  • Birmingham, Alabama
  • +9 more
May 7, 2021

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • (no location specified)
Sep 5, 2023

Multiple Myeloma (MM), Cancer Trial in Worldwide (ABBV-467)

Terminated
  • Multiple Myeloma (MM)
  • Cancer
  • Tucson, Arizona
  • +23 more
Jul 20, 2021

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

Completed
Has Results
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC V7
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021

Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +29 more
Jun 29, 2021